Novel activating mutations lacking cysteine in type i cytokine receptors in acute lymphoblastic leukemia

Blood

Volumn 124, Issue 1, 2014, Pages 106-110

  Shochat, Chen ^a,b,c,d   Tal, Noa ^a,c   Gryshkova, Vitalina ^e   Birger, Yehudit ^a   Bandapalli, Obul R ^f,g   Cazzaniga, Giovanni ^h   Gershman, Nava ^a,i   Kulozik, Andreas E ^f,g   Biondi, Andrea ^h   Mansour, Marc R ^j,k   Twizere, Jean Claude ^l   Muckenthaler, Martina U ^f,g   Ben Tal, Nir ^c   Constantinescu, Stefan N ^e   Bercovich, Dani ^b,d   Izraeli, Shai ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d TEL HAI COLLEGE   (Israel)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g Molecular Medicine Partnership Unit   (Germany)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ BAR ILAN UNIVERSITY   (Israel)

^j DANA FARBER CANCER INSTITUTE   (United States)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF LIÈGE   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYTOKINE RECEPTOR; CYTOKINE RECEPTOR LIKE FACTOR 2; CYTOKINE RECEPTOR TYPE 1; INTERLEUKIN 7 RECEPTOR ALPHA; UNCLASSIFIED DRUG; CRLF2 PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIMERIZATION; FEMALE; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FRAGMENT COMPLEMENTATION ASSAY; SOMATIC MUTATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; CYSTEINE; DNA MUTATIONAL ANALYSIS; FEMALE; FLOW CYTOMETRY; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 84903948818     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-529685     Document Type: Article

References (19)

1. Tal N, Shochat C, Geron I, Bercovich D, Izraeli S. Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia. Cell Mol Life Sci. 2014;71(3):365-378.
2. Wang X, Lupardus P, Laporte SL, Garcia KC. Structural biology of shared cytokine receptors. Annu Rev Immunol. 2009;27:29-60.
3. Yoda A, Yoda Y, Chiaretti S, et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2010;107(1):252-257.
4. Shochat C, Tal N, Bandapalli OR, et al. Gain-of-function mutations in interleukin-7 receptor-a (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med. 2011; 208(5):901-908.
5. Zenatti PP, Ribeiro D, Li W, et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet. 2011; 43(10):932-939.
6. Kubatzky KF, Liu W, Goldgraben K, Simmerling C, Smith SO, Constantinescu SN. Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function. J Biol Chem. 2005;280(15): 14844-14854. (Pubitemid 40562834)
7. Lu X, Gross AW, Lodish HF. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem. 2006;281(11):7002-7011. (Pubitemid 43847463)
8. Hertzberg L, Vendramini E, Ganmore I, et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010;115(5):1006-1017.
9. Bercovich D, Ganmore I, Scott LM, et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet. 2008;372(9648):1484-1492.
10. Remy I, Michnick SW. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods. 2006;3(12): 977-979. (Pubitemid 44782695)
11. Rochman Y, Kashyap M, Robinson GW, et al. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci USA. 2010;107(45): 19455-19460.
12. Rose T, Pillet AH, Lavergne V, et al. Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response. J Biol Chem. 2010;285(20):14898-14908.
13. Armon A, Graur D, Ben-Tal N. ConSurf: an algorithmic tool for the identification of functional regions in proteins by surface mapping of phylogenetic information. J Mol Biol. 2001; 307(1):447-463. (Pubitemid 33029992)
14. Bargmann CI, Hung MC, Weinberg RA. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 1986;45(5):649-657. (Pubitemid 16063129)
15. Beevers AJ, Nash A, Salazar-Cancino M, Scott DJ, Notman R, Dixon AM. Effects of the oncogenic V(664)E mutation on membrane insertion, structure, and sequence-dependent interactions of the Neu transmembrane domain in micelles and model membranes: an integrated biophysical and simulation study. Biochemistry. 2012;51(12):2558-2568.
16. Fleishman SJ, Schlessinger J, Ben-Tal N. A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci USA. 2002;99(25):15937-15940. (Pubitemid 35462727)
17. Onishi M, Mui AL, Morikawa Y, et al. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirusmediated gene transfer. Blood. 1996;88(4): 1399-1406. (Pubitemid 26276816)
18. Defour JP, Itaya M, Gryshkova V, et al. Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation. Proc Natl Acad Sci USA. 2013;110(7):2540-2545.
19. Ding J, Komatsu H, Iida S, et al. The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. Blood. 2009;114(15): 3325-3328.